keyword
https://read.qxmd.com/read/38653552/pharmacological-treatments-for-alcohol-dependence-evidence-on-uptake-inequalities-and-comparative-effectiveness-from-a-uk-population-based-cohort
#21
JOURNAL ARTICLE
Francesco Manca, Lisong Zhang, Niamh Fitzgerald, Frederick Ho, Hamish Innes, Bhautesh Jani, Srinivasa Vittal Katikireddi, Andrew McAuley, Clare Sharp, Jim Lewsey
INTRODUCTION: We assessed the prevalence of prescribing of certain medications for alcohol dependence and the extent of any inequalities in receiving prescriptions for individuals with such a diagnosis. Further, we compared the effectiveness of two of the most prescribed medications (acamprosate and disulfiram) for alcohol dependence and assessed whether there is inequality in prescribing either of them. METHODS: We used a nationwide dataset on prescriptions and hospitalisations in Scotland, UK (N = 19,748)...
April 23, 2024: Drug and Alcohol Review
https://read.qxmd.com/read/38653508/epirubicin-for-the-treatment-of-sepsis-and-septic-shock-epos-1-study-protocol-for-a-randomised-placebo-controlled-phase-iia-dose-escalation-trial
#22
RANDOMIZED CONTROLLED TRIAL
Daniel Thomas-Rüddel, Michael Bauer, Luís Ferreira Moita, Christiane Helbig, Peter Schlattmann, Johannes Ehler, Tim Rahmel, Patrick Meybohm, Matthias Gründling, Heiko Schenk, Thomas Köcher, Frank M Brunkhorst, Markus Gräler, Ann-Julika Heger, Sebastian Weis
INTRODUCTION: Sepsis remains the major cause of death among hospitalised patients in intensive care. While targeting sepsis-causing pathogens with source control or antimicrobials has had a dramatic impact on morbidity and mortality of sepsis patients, this strategy remains insufficient for about one-third of the affected individuals who succumb. Pharmacological targeting of mechanisms that reduce sepsis-defining organ dysfunction may be beneficial. When given at low doses, the anthracycline epirubicin promotes tissue damage control and lessens the severity of sepsis independently of the host-pathogen load by conferring disease tolerance to infection...
April 22, 2024: BMJ Open
https://read.qxmd.com/read/38653401/stimulating-intestinal-gip-release-reduces-food-intake-and-body-weight-in-mice
#23
JOURNAL ARTICLE
Jo E Lewis, Danae Nuzzaci, Paula-Peace James-Okoro, Mireia Montaner, Elisabeth O'Flaherty Rottenberger, Tamana Darwish, Marito Hayashi, Stephen D Liberles, David Hornigold, Jacqueline Naylor, David Baker, Fiona M Gribble, Frank Reimann
OBJECTIVE: Glucose dependent insulinotropic polypeptide (GIP) is well established as an incretin hormone, boosting glucose-dependent insulin secretion. However, whilst anorectic actions of its sister-incretin glucagon-like peptide-1 (GLP-1) are well established, a physiological role for GIP in appetite regulation is controversial, despite the superior weight loss seen in preclinical models and humans with GLP-1/GIP dual receptor agonists compared with GLP-1R agonism alone. METHODS: We generated a mouse model in which GIP expressing K-cells can be activated through hM3Dq Designer Receptor Activated by Designer Drugs (DREADD, GIP-Dq) to explore physiological actions of intestinally-released GIP...
April 21, 2024: Molecular Metabolism
https://read.qxmd.com/read/38653371/pleiotropic-role-of-gas6-in-cardioprotection-against-ischemia-reperfusion-injury
#24
JOURNAL ARTICLE
Chenxi Lu, Yanbin Song, Xiaopeng Wu, Wangrui Lei, Junmin Chen, Xin Zhang, Qiong Liu, Chao Deng, Zhenxing Liang, Ying Chen, Jun Ren, Yang Yang
INTRODUCTION: Myocardial ischemia-reperfusion (IR) injury is a common medical issue contributing to the onset and progression of ischemic heart diseases (IHD). Growth arrest-specific gene 6 (GAS6) is vitamin K-dependent secretory protein, to promote cell proliferation and inhibit inflammation and apoptosis through binding with Tyro3, Axl, and Mertk (TAM) receptors. OBJECTIVES: Our study aimed to examine the effect of GAS6 pathways activation as a potential new treatment in myocardial ischemia-reperfusion (IR) injury...
April 21, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38653114/controlling-autoimmune-diabetes-onset-by-targeting-protease-activated-receptor-2
#25
JOURNAL ARTICLE
Gal Reches, Lynn Khoon, Narmeen Ghanayiem, Assaf Malka, Ron Piran
BACKGROUND: Type 1 diabetes (T1D) is a challenging autoimmune disease, characterized by an immune system assault on insulin-producing β-cells. As insulin facilitates glucose absorption into cells and tissues, β-cell deficiency leads to elevated blood glucose levels on one hand and target-tissues starvation on the other. Despite efforts to halt β-cell destruction and stimulate recovery, success has been limited. Our recent investigations identified Protease-Activated Receptor 2 (Par2) as a promising target in the battle against autoimmunity...
April 22, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38653112/engineering-the-protein-corona-strategies-effects-and-future-directions-in-nanoparticle-therapeutics
#26
REVIEW
Tianyu Zhao, Mingli Ren, Jiajie Shi, Haijiao Wang, Jing Bai, Wenli Du, Bai Xiang
Nanoparticles (NPs) serve as versatile delivery systems for anticancer, antibacterial, and antioxidant agents. The manipulation of protein-NP interactions within biological systems is crucial to the application of NPs in drug delivery and cancer nanotherapeutics. The protein corona (PC) that forms on the surface of NPs is the interface between biomacromolecules and NPs and significantly influences their pharmacokinetics and pharmacodynamics. Upon encountering proteins, NPs undergo surface alterations that facilitate their clearance from circulation by the mononuclear phagocytic system (MPS)...
April 22, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38653111/lapatinib-combined-with-doxorubicin-causes-dose-dependent-cardiotoxicity-partially-through-activating-the-p38mapk-signaling-pathway-in-zebrafish-embryos
#27
JOURNAL ARTICLE
Ke Du, Yuting Liu, Lu Zhang, Lixia Peng, Wenjing Dong, Yajie Jiang, Mingming Niu, Yuanchao Sun, Chuanhong Wu, Yujuan Niu, Yonghe Ding
Because of its enhanced antitumor efficacy, lapatinib (LAP) is commonly used clinically in combination with the anthracycline drug doxorubicin (DOX) to treat metastatic breast cancer. While it is well recognized that this combination chemotherapy can lead to an increased risk of cardiotoxicity in adult women, its potential cardiotoxicity in the fetus during pregnancy remains understudied. Here, we aimed to examine the combination of LAP chemotherapy and DOX-induced cardiotoxicity in the fetus using a zebrafish embryonic system and investigate the underlying pathologic mechanisms...
April 22, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38652975/differential-age-specific-associations-of-ldl-cholesterol-and-body-mass-index-with-coronary-heart-disease
#28
JOURNAL ARTICLE
Jun Xiao, Hongye Wei, Ziting Gao, Liangwan Chen, Weimin Ye, Wuqing Huang
BACKGROUND AND AIMS: Low-density lipoprotein cholesterol (LDLc) and body mass index (BMI) are not always correlated and their relationship is probably dependent on age, indicating differential age-specific associations of these factors with health outcomes. We aim to discriminate the roles of LDLc and BMI in coronary heart disease (CHD) across different age groups. METHODS: This is a prospective cohort study of 368,274 participants aged 38-73 years and free of CHD at baseline...
April 11, 2024: Atherosclerosis
https://read.qxmd.com/read/38652958/geniposide-ameliorates-psoriatic-skin-inflammation-by-inhibiting-the-tlr4-myd88-nf-%C3%AE%C2%BAb-p65-signaling-pathway-and-mmp9
#29
JOURNAL ARTICLE
Lijuan Liu, Huiling Zhang, Xinran Tang, Mengge Zhang, Yayun Wu, Ya Zhao, Chuanjian Lu, Ruizhi Zhao
Psoriasis is an incurable immune-mediated disease affecting the skin or the joints. There are continuing studies on drugs for psoriasis prevention and treatment. This research found that Geniposide (GE) significantly thinned IMQ mice's skin lesions, reduced the scales, and lowered the presence of inflammatory cells in the pathology in a dose-dependent manner. GE inhibited IL-23, IL-22, IL-17A, IL-12, IL-6, and TNF-α levels in psoriatic mice serum. AKT1, TNF, TLR4, MMP9, MAPK3, and EGFR were selected as the top 6 targets of GE against psoriasis via network pharmacology, and GE-TLR4 has the most robust docking score value by molecular docking...
April 22, 2024: International Immunopharmacology
https://read.qxmd.com/read/38652546/threonine-dehydrogenase-regulates-neutrophil-homeostasis-but-not-h3k4me3-levels-in-zebrafish
#30
JOURNAL ARTICLE
Ning-Zhe Li, Zi-Xuan Wang, Fan Zhang, Chang-Zhou Feng, Yi Chen, Dian-Jia Liu, Shu-Bei Chen, Yi Jin, Yuan-Liang Zhang, Yin-Yin Xie, Qiu-Hua Huang, Lan Wang, Bing Li, Xiao-Jian Sun
l-threonine dehydrogenase (Tdh) is an enzyme that links threonine metabolism to epigenetic modifications and mitochondria biogenesis. In vitro studies show that it is critical for the regulation of trimethylation of histone H3 lysine 4 (H3K4me3) levels and cell fate determination of mouse embryonic stem cells (mESCs). However, whether Tdh regulates a developmental process in vivo and, if it does, whether it also primarily regulates H3K4me3 levels in this process as it does in mESCs, remains elusive. Here, we revealed that, in zebrafish hematopoiesis, tdh is preferentially expressed in neutrophils...
April 23, 2024: FEBS Journal
https://read.qxmd.com/read/38652112/characterizing-the-nonlinear-pharmacokinetics-and-pharmacodynamics-of-bi-187004-an-11%C3%AE-hydroxysteroid-dehydrogenase-type-1-inhibitor-in-humans-by-a-target-mediated-drug-disposition-model
#31
JOURNAL ARTICLE
Xuanzhen Yuan, Guohua An
BI 187004, a selective small-molecule inhibitor of 11β-hydroxysteroid dehydrogenase-1 (11β-HSD1), displayed complex nonlinear pharmacokinetics (PK) in humans. Following nine single oral doses, BI 187004 exhibited nonlinear PK at low doses and linear PK at higher doses. Notably, substantial hepatic 11β-HSD1 inhibition (50%) was detected in a very low-dose group, achieving a consistent 70% hepatic enzyme inhibition in subsequent ascending doses without any dose-dependent effects. The unusual PK and PD profiles of BI 187004 suggest the presence of pharmacological target-mediated drug disposition (TMDD), arising from the saturable binding of BI 187004 compound to its high-affinity and low-capacity target 11β-HSD1...
April 23, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38651981/nsc689857-an-inhibitor-of-skp2-produces-antidepressant-like-effects-in-mice
#32
JOURNAL ARTICLE
Qingqing Liu, Li Cheng, Fu Li, Haojie Zhu, Xu Lu, Chao Huang, Xiaomei Yuan
We have previously reported that two inhibitors of an E3 ligase S-phase kinase-associated protein 2 (Skp2), SMIP004 and C1, have an antidepressant-like effect in non-stressed and chronically stressed mice. This prompted us to ask whether other Skp2 inhibitors could also have an antidepressant effect. Here, we used NSC689857, another Skp2 inhibitor, to investigate this hypothesis. The results showed that administration of NSC689857 (5 mg/kg) produced an antidepressant-like effect in a time-dependent manner in non-stressed male mice, which started 8 days after drug administration...
April 24, 2024: Behavioural Pharmacology
https://read.qxmd.com/read/38651940/a-mouse-model-of-progressive-lung-fibrosis-with-cutaneous-involvement-induced-by-a-combination-of-oropharyngeal-and-osmotic-minipump-bleomycin-delivery
#33
JOURNAL ARTICLE
Andrea Grandi, Erica Ferrini, Matteo Zoboli, Davide Buseghin, Francesca Pennati, Zahra Khalajzeyqami, Roberta Ciccimarra, Gino Villetti, Franco Fabio Stellari
Systemic sclerosis (SSc) with interstitial lung disease (SSc-ILD) lacks curative pharmacological treatments, thus necessitating effective animal models for candidate drug discovery. Existing Bleomycin (BLM)-induced SSc-ILD mouse models feature spatially limited pulmonary fibrosis, spontaneously resolving after 28 days. Here, we present an alternative BLM administration approach in female C57BL/6 mice, combining oropharyngeal aspiration (OA) and subcutaneous mini-pump delivery (pump) of BLM to induce a sustained and more persistent fibrosis, while retaining stable skin fibrosis...
April 23, 2024: American Journal of Physiology. Lung Cellular and Molecular Physiology
https://read.qxmd.com/read/38651930/reduction-of-product-composition-variability-using-pooled-microbiome-ecosystem-therapy-and-consequence-in-two-infectious-murine-models
#34
JOURNAL ARTICLE
Julie Reygner, Johanne Delannoy, Marie-Thérèse Barba-Goudiaby, Cyrielle Gasc, Benoît Levast, Enora Gaschet, Laurent Ferraris, Stéphane Paul, Nathalie Kapel, Anne-Judith Waligora-Dupriet, Frederic Barbut, Muriel Thomas, Carole Schwintner, Bastien Laperrousaz, Nathalie Corvaïa
Growing evidence demonstrates the key role of the gut microbiota in human health and disease. The recent success of microbiotherapy products to treat recurrent Clostridioides difficile infection has shed light on its potential in conditions associated with gut dysbiosis, such as acute graft-versus-host disease, intestinal bowel diseases, neurodegenerative diseases, or even cancer. However, the difficulty in defining a "good" donor as well as the intrinsic variability of donor-derived products' taxonomic composition limits the translatability and reproducibility of these studies...
April 23, 2024: Applied and Environmental Microbiology
https://read.qxmd.com/read/38651855/altered-serine-metabolism-promotes-drug-tolerance-in-mycobacterium-abscessus-via-a-whib7-mediated-adaptive-stress-response
#35
JOURNAL ARTICLE
Célia Bernard, Yi Liu, Gérald Larrouy-Maumus, Christophe Guilhot, Kaymeuang Cam, Christian Chalut
Mycobacterium abscessus is an emerging opportunistic pathogen responsible for chronic lung diseases, especially in patients with cystic fibrosis. Treatment failure of M. abscessus infections is primarily associated with intrinsic or acquired antibiotic resistance. However, there is growing evidence that antibiotic tolerance, i.e., the ability of bacteria to transiently survive exposure to bactericidal antibiotics through physiological adaptations, contributes to the relapse of chronic infections and the emergence of acquired drug resistance...
April 23, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38651620/acceptor-reactivity-controlled-stereoconvergent-synthesis-and-immunological-activity-of-a-unique-pentasaccharide-from-the-cell-wall-polysaccharide-of-cutibacterium-acnes-c7
#36
JOURNAL ARTICLE
Tianhui Hao, Ke Feng, Hongzhen Jin, Jiawei Li, Chenkai Zhou, Xingbang Liu, Wei Zhao, Fan Yu, Tiehai Li
Bacterial cell-surface polysaccharides are involved in various biological processes and have attracted widespread attention as potential targets for developing carbohydrate-based drugs. However, the accessibility of structurally well-defined polysaccharide or related active oligosaccharide domains remains challenging. Herein, we describe an efficiently stereocontrolled approach for the first total synthesis of a unique pentasaccharide repeating unit containing four difficult-to-construct 1,2-cis-glycosidic linkages from the cell wall polysaccharide of Cutibacterium acnes C7...
April 23, 2024: Angewandte Chemie
https://read.qxmd.com/read/38651522/development-of-prolinol-containing-inhibitors-of-hypoxanthine-guanine-xanthine-phosphoribosyltransferase-rational-structure-based-drug-design
#37
JOURNAL ARTICLE
Dianne T Keough, Magdalena Petrová, Gordon King, Michal Kratochvíl, Radek Pohl, Eva Doleželová, Alena Zíková, Luke W Guddat, Dominik Rejman
Inhibition of hypoxanthine-guanine-xanthine phosphoribosyltransferase activity decreases the pool of 6-oxo and 6-amino purine nucleoside monophosphates required for DNA and RNA synthesis, resulting in a reduction in cell growth. Therefore, inhibitors of this enzyme have potential to control infections, caused by Plasmodium falciparum and Plasmodium vivax , Trypanosoma brucei , Mycobacterium tuberculosis , and Helicobacter pylori . Five compounds synthesized here that contain a purine base covalently linked by a prolinol group to one or two phosphonate groups have K i values ranging from 3 nM to >10 μM, depending on the structure of the inhibitor and the biological origin of the enzyme...
April 23, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38651259/phase-separation-methods-for-protein-purification-a-meta-analysis-of-purification-performance-and-cost-effectiveness
#38
JOURNAL ARTICLE
John S Decker, Utsuki Yano, Romel Menacho Melgar, Michael D Lynch
Protein purifications based on phase separations (e.g., precipitation and liquid-liquid extraction) have seen little adoption in commercial protein drug production. To identify barriers, we analyzed the purification performance and economics of 290 phase separation purifications from 168 publications. First, we found that studies using Design of Experiments for optimization achieved significantly greater mean yield and host cell protein log10 removal values than those optimizing one factor at a time (11.5% and 53% increases, respectively)...
April 2024: Biotechnology Journal
https://read.qxmd.com/read/38651236/signalling-switches-maintain-intercellular-communication-in-the-vascular-endothelium
#39
JOURNAL ARTICLE
Charlotte Buckley, Matthew D Lee, Xun Zhang, Calum Wilson, John G McCarron
BACKGROUND AND PURPOSE: The single layer of cells lining all blood vessels, the endothelium, is a sophisticated signal co-ordination centre that controls a wide range of vascular functions including the regulation of blood pressure and blood flow. To co-ordinate activities, communication among cells is required for tissue level responses to emerge. While a significant form of communication occurs by the propagation of signals between cells, the mechanism of propagation in the intact endothelium is unresolved...
April 23, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38651213/drug-testing-of-monodisperse-arrays-of-live-microdissected-tumors-using-a-valved-multiwell-microfluidic-platform
#40
JOURNAL ARTICLE
Ethan J Lockhart, Lisa F Horowitz, Adán Rodríguez, Songli Zhu, Tran Nguyen, Mehdi Mehrabi, Taranjit S Gujral, Albert Folch
Cancer drug testing in animals is an extremely poor predictor of the drug's safety and efficacy observed in humans. Hence there is a pressing need for functional testing platforms that better predict traditional and immunotherapy responses in human, live tumor tissue or tissue constructs, and at the same time are compatible with the use of mouse tumor tissue to facilitate building more accurate disease models. Since many cancer drug actions rely on mechanisms that depend on the tumor microenvironment (TME), such platforms should also retain as much of the native TME as possible...
April 23, 2024: Lab on a Chip
keyword
keyword
3338
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.